Fate Therapeutics, Inc. (FATE)
USD 0.88
(-3.27%)
USD 0.88
(-3.27%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -98.16 Million USD | -45.18% |
| 2022 | 82.54 Million USD | 65.1% |
| 2021 | 49.99 Million USD | 153.08% |
| 2020 | -94.18 Million USD | -22.18% |
| 2019 | -77.09 Million USD | -50.32% |
| 2018 | -51.28 Million USD | -69.52% |
| 2017 | -30.25 Million USD | -37.2% |
| 2016 | -22.05 Million USD | -26.51% |
| 2015 | -17.43 Million USD | -6.05% |
| 2014 | -16.43 Million USD | -48.92% |
| 2013 | -11.03 Million USD | -18.3% |
| 2012 | -9.32 Million USD | -897.35% |
| 2011 | 1.17 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 2.05 Million USD | -861.05% |
| 2024 Q1 | -2.89 Million USD | 9.75% |
| 2023 Q2 | -3.53 Million USD | -106.45% |
| 2023 Q1 | 54.78 Million USD | 38.66% |
| 2023 FY | 45.25 Million USD | -45.18% |
| 2023 Q3 | -2.79 Million USD | 20.86% |
| 2023 Q4 | -3.2 Million USD | -14.77% |
| 2022 Q2 | -62.75 Million USD | -16.81% |
| 2022 FY | 82.54 Million USD | 65.1% |
| 2022 Q4 | 39.51 Million USD | 235.21% |
| 2022 Q3 | 11.78 Million USD | 118.78% |
| 2022 Q1 | -53.72 Million USD | -2.43% |
| 2021 Q2 | -34.61 Million USD | -2.67% |
| 2021 FY | 49.99 Million USD | 153.08% |
| 2021 Q4 | -52.44 Million USD | -34.81% |
| 2021 Q3 | -38.9 Million USD | -12.41% |
| 2021 Q1 | -33.71 Million USD | -46.02% |
| 2020 Q4 | -23.08 Million USD | 0.22% |
| 2020 FY | -94.18 Million USD | -22.18% |
| 2020 Q3 | -23.13 Million USD | -9.11% |
| 2020 Q2 | -21.2 Million USD | 20.77% |
| 2020 Q1 | -26.76 Million USD | -19.44% |
| 2019 Q4 | -22.4 Million USD | -7.87% |
| 2019 Q3 | -20.77 Million USD | -10.41% |
| 2019 Q2 | -18.81 Million USD | -24.63% |
| 2019 FY | -77.09 Million USD | -50.32% |
| 2019 Q1 | -15.09 Million USD | -21.41% |
| 2018 Q1 | -10.45 Million USD | -17.95% |
| 2018 FY | -51.28 Million USD | -69.52% |
| 2018 Q4 | -12.43 Million USD | 1.4% |
| 2018 Q3 | -12.61 Million USD | 20.13% |
| 2018 Q2 | -15.78 Million USD | -51.09% |
| 2017 Q1 | -6.93 Million USD | -33.37% |
| 2017 FY | -30.25 Million USD | -37.2% |
| 2017 Q4 | -8.86 Million USD | -17.32% |
| 2017 Q3 | -7.55 Million USD | -9.43% |
| 2017 Q2 | -6.9 Million USD | 0.55% |
| 2016 FY | -22.05 Million USD | -26.51% |
| 2016 Q4 | -5.2 Million USD | 9.95% |
| 2016 Q3 | -5.77 Million USD | -0.4% |
| 2016 Q2 | -5.75 Million USD | -8.3% |
| 2016 Q1 | -5.31 Million USD | -21.96% |
| 2015 Q2 | -4.52 Million USD | 0.88% |
| 2015 FY | -17.43 Million USD | -6.05% |
| 2015 Q4 | -4.35 Million USD | -9.55% |
| 2015 Q3 | -3.97 Million USD | 12.17% |
| 2015 Q1 | -4.56 Million USD | -18.19% |
| 2014 Q2 | -3.96 Million USD | 12.25% |
| 2014 Q1 | -4.52 Million USD | -12.99% |
| 2014 Q4 | -3.86 Million USD | 5.27% |
| 2014 FY | -16.43 Million USD | -48.92% |
| 2014 Q3 | -4.08 Million USD | -2.82% |
| 2013 Q3 | -3.16 Million USD | -14.12% |
| 2013 Q1 | -2.05 Million USD | 25.4% |
| 2013 FY | -11.03 Million USD | -18.3% |
| 2013 Q4 | -4 Million USD | -26.29% |
| 2013 Q2 | -2.77 Million USD | -34.87% |
| 2012 Q3 | -2.78 Million USD | 0.0% |
| 2012 FY | -9.32 Million USD | -897.35% |
| 2012 Q4 | -2.76 Million USD | 0.97% |
| 2011 FY | 1.17 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 106.467% |
| AlloVir, Inc. | -398 Thousand USD | -24564.07% |
| Aptorum Group Limited | -1.11 Million USD | -8706.321% |
| Ardelyx, Inc. | 106.66 Million USD | 192.033% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 140.776% |
| Bicycle Therapeutics plc | -129.52 Million USD | 24.21% |
| AbCellera Biologics Inc. | 38.02 Million USD | 358.154% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 81902.5% |
| Chimerix, Inc. | 324 Thousand USD | 30397.222% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -214.951% |
| Elevation Oncology, Inc. | -39 Thousand USD | -251600.0% |
| Alkermes plc | 1.37 Billion USD | 107.141% |
| Fortress Biotech, Inc. | 57.85 Million USD | 269.677% |
| Fortress Biotech, Inc. | 57.85 Million USD | 269.677% |
| Agenus Inc. | 139.61 Million USD | 170.31% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 692.164% |
| Dyadic International, Inc. | 922.95 Thousand USD | 10735.707% |
| ImmuCell Corporation | 4.39 Million USD | 2332.863% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 566.089% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 7.501% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -56043.512% |
| Immix Biopharma, Inc. | -5468.00 USD | -1795126.774% |
| Incyte Corporation | 3.44 Billion USD | 102.853% |
| IO Biotech, Inc. | -756 Thousand USD | -12884.524% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -109.575% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -634.871% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -222048.547% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 0.055% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -14683.584% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -178378.182% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -1963160.0% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 181.971% |
| ContextLogic Inc. | 59 Million USD | 266.378% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 12339.776% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -18526.755% |
| MiMedx Group, Inc. | 266.84 Million USD | 136.787% |
| MEI Pharma, Inc. | 49.32 Million USD | 299.005% |
| Novavax, Inc. | 639.93 Million USD | 115.339% |
| NextCure, Inc. | -3.68 Million USD | -2564.577% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 615.481% |
| Onconetix, Inc. | -1.12 Million USD | -8608.84% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -238.867% |
| Opthea Limited | 21.72 Thousand USD | 452047.514% |
| Psyence Biomedical Ltd. | -240.00 USD | -40901150.0% |
| Vaxcyte, Inc. | -75 Million USD | -30.884% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -171136.437% |
| Precigen, Inc. | 106 Thousand USD | 92706.604% |
| Pharming Group N.V. | 220.1 Million USD | 144.598% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 19160.777% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 9828.741% |
| PureTech Health plc | -1.6 Million USD | -6023.706% |
| Pyxis Oncology, Inc. | -2 Million USD | -4808.15% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 189.424% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 45.888% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -18896.373% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Seer, Inc. | 7.02 Million USD | 1496.94% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -116.576% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -346.459% |
| Acelyrin, Inc. | -115 Thousand USD | -85259.13% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -976549.09% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -17091.419% |
| Senti Biosciences, Inc. | -2.68 Million USD | -3558.703% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1347.148% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 2523.179% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -1945.915% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -2390.152% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 436.994% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 19890.927% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 23251.651% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -119610.976% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 194.298% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 172.569% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -1.251% |
| ChromaDex Corporation | 50.78 Million USD | 293.31% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 434.035% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -42211.638% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -19851.829% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -26.502% |
| CRISPR Therapeutics AG | 240.95 Million USD | 140.739% |
| Precision BioSciences, Inc. | 40.47 Million USD | 342.545% |
| Innoviva, Inc. | 261.06 Million USD | 137.601% |
| Jaguar Health, Inc. | 7.72 Million USD | 1370.883% |
| Summit Therapeutics Inc. | -2.05 Million USD | -4688.439% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 2342.188% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 555.618% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -82744.267% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -68401.267% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 16218.719% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 181.481% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 131.295% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 3913.636% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -193362.751% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -1282.967% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -20585.709% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -943775.0% |
| Soligenix, Inc. | 97.31 Thousand USD | 100975.543% |
| Century Therapeutics, Inc. | -10.8 Million USD | -808.16% |
| Kura Oncology, Inc. | -849 Thousand USD | -11462.191% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -46.285% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -66677.551% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 199.115% |
| Autolus Therapeutics plc | -4.86 Million USD | -1916.91% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 337.189% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -58330.357% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 203.632% |
| GRI Bio, Inc. | 10.84 Million USD | 1005.479% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 3964.706% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -1029.999% |
| IGM Biosciences, Inc. | -211.66 Million USD | 53.622% |
| INmune Bio, Inc. | 155 Thousand USD | 63430.968% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 258.483% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -6416.868% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -15038.005% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -335224.862% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 24518.657% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -4817.986% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -31261.981% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 203.919% |
| Verastem, Inc. | -62 Thousand USD | -158227.419% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 4131.335% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -37510.345% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 3342.914% |
| Histogen Inc. | 3.76 Million USD | 2704.484% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 17136.893% |
| Surrozen, Inc. | -27.23 Million USD | -260.496% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1721.544% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -8047.118% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -282.747% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 589.542% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -4957627.273% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1718.136% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -146126.036% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 163.416% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 67427.16% |
| Apollomics, Inc. | 127 Thousand USD | 77393.701% |
| Amarin Corporation plc | 165.54 Million USD | 159.298% |
| Mesoblast Limited | -9.81 Million USD | -900.132% |
| Turnstone Biologics Corp. | 16.5 Million USD | 694.711% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 11.156% |
| Synaptogenix, Inc. | -6347.00 USD | -1546504.695% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -192376.471% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 160.833% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 105.585% |
| Better Therapeutics, Inc. | -2.72 Million USD | -3497.032% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 12.48% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 129.035% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -860375.105% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1468.099% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -8759.477% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1441.391% |
| Insmed Incorporated | 239.63 Million USD | 140.964% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 2843.516% |
| OmniAb, Inc. | 14.66 Million USD | 769.278% |
| Alector, Inc. | -95.05 Million USD | -3.272% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 178.142% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -125.854% |
| Zai Lab Limited | 170.9 Million USD | 157.438% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 219.891% |
| Aura Biosciences, Inc. | -1.29 Million USD | -7480.154% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 75610.0% |
| Immunic, Inc. | -111 Thousand USD | -88335.135% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 719.169% |
| Veracyte, Inc. | 248.14 Million USD | 139.558% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.595% |
| FibroGen, Inc. | 128.9 Million USD | 176.152% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -17404687.234% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -741.381% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 102.888% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 25334.704% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 127.625% |
| TG Therapeutics, Inc. | 219.1 Million USD | 144.801% |
| Galecto, Inc. | -830 Thousand USD | -11726.867% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -6987.581% |
| Fortrea Holdings Inc. | 424 Million USD | 123.152% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -13.922% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -17212.698% |
| XBiotech Inc. | -1.74 Million USD | -5528.612% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -8759.477% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -111.235% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -29.959% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 233.732% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 684.199% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 125.232% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -97.722% |
| Vaxxinity, Inc. | -2.23 Million USD | -4294.047% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 130.042% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -766.87% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 501.468% |
| NexImmune, Inc. | -1.02 Million USD | -9477.14% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 1817933.333% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -1281.477% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.869% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -146791.227% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -2664.376% |
| Ainos, Inc. | -253.73 Thousand USD | -38587.518% |
| Pluri Inc. | 322 Thousand USD | 30585.404% |
| Prothena Corporation plc | -129.2 Million USD | 24.023% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 294.675% |
| Celularity Inc. | 6.75 Million USD | 1553.19% |
| Rallybio Corporation | -150 Thousand USD | -65342.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | -201.049% |
| MeiraGTx Holdings plc | 287 Thousand USD | 34303.136% |
| Omeros Corporation | -69.77 Million USD | -40.677% |
| Humacyte, Inc. | -76.55 Million USD | -28.234% |
| Immunocore Holdings plc | 248.39 Million USD | 139.52% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -547.129% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 257.358% |
| Blueprint Medicines Corporation | 236.58 Million USD | 141.492% |
| CalciMedica, Inc. | -58 Thousand USD | -169146.552% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -6783.801% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 437.852% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -3351.582% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -218.04% |
| Pulmatrix, Inc. | -8.22 Million USD | -1094.197% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -8290.0% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -24502.256% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 75.385% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 3636.66% |
| Cytokinetics, Incorporated | -322.59 Million USD | 69.571% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 11486.432% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -28686.804% |
| Vor Biopharma Inc. | -3.49 Million USD | -2711.082% |
| Roivant Sciences Ltd. | 109.23 Million USD | 189.864% |
| Evogene Ltd. | 1.39 Million USD | 7116.655% |
| ProKidney Corp. | -3.16 Million USD | -2997.602% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -123.545% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1531.574% |
| CorMedix Inc. | -205.56 Thousand USD | -47653.476% |
| BioLineRx Ltd. | 1.1 Million USD | 8959.477% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -24.777% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -297363.636% |
| Atai Life Sciences N.V. | -5000.00 USD | -1963160.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -80454.575% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -102153.125% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -6967.171% |
| Sagimet Biosciences Inc. | 2 Million USD | 5008.15% |
| MediciNova, Inc. | 979.7 Thousand USD | 10119.649% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -16.419% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -103715.769% |
| GeoVax Labs, Inc. | -20.72 Million USD | -373.742% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 140.143% |
| Biomea Fusion, Inc. | -4.2 Million USD | -2236.658% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 111.253% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1421.883% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -31565.484% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -817925.0% |
| Absci Corporation | -41.84 Million USD | -134.565% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1963160.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -28.531% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -3888.744% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 145.927% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -10331.775% |
| Allakos Inc. | -6.14 Million USD | -1498.486% |
| Imunon, Inc. | -720 Thousand USD | -13533.655% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -42.273% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 120.627% |
| BioAtla, Inc. | -103.73 Million USD | 5.368% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -860375.105% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -55047.753% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 59.574% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -31463.666% |
| XOMA Corporation | 3.86 Million USD | 2642.424% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -40.063% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 763.533% |
| aTyr Pharma, Inc. | -2.38 Million USD | -4010.678% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 887.825% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -338393.103% |
| Viridian Therapeutics, Inc. | -1 Million USD | -9638.393% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 755100100.0% |
| Akari Therapeutics, Plc | -4000.00 USD | -2453975.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 115.413% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 50515.494% |
| UroGen Pharma Ltd. | 73.35 Million USD | 233.825% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -267.734% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 845603.876% |
| Orgenesis Inc. | -5.72 Million USD | -1614.638% |
| Entera Bio Ltd. | -56 Thousand USD | -175191.071% |
| GH Research PLC | -315 Thousand USD | -31062.857% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -51838.095% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -18597.714% |
| Xencor, Inc. | -85.26 Million USD | -15.134% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -44322.27% |
| Replimune Group, Inc. | -2.65 Million USD | -3597.288% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -9704.182% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 155.196% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 50515.494% |
| Portage Biotech Inc. | -54 Thousand USD | -181683.333% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -103715.769% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -25937.931% |
| OncoCyte Corporation | 413 Thousand USD | 23868.281% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -2183726.474% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -44217467.568% |
| Purple Biotech Ltd. | -196 Thousand USD | -49983.163% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 1194.592% |
| scPharmaceuticals Inc. | 9.78 Million USD | 1103.506% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -839.812% |
| HilleVax, Inc. | -2.15 Million USD | -4453.015% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -101098.969% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -654145.535% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -14595.06% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -426695.652% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1307665.888% |
| Savara Inc. | -44.26 Million USD | -121.777% |
| Curis, Inc. | 9.81 Million USD | 1100.54% |
| Daré Bioscience, Inc. | 2.76 Million USD | 3644.402% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -78563.814% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -5577.444% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -42953.947% |
| BeiGene, Ltd. | 2.07 Billion USD | 104.722% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -3410.962% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 75.439% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 273.164% |
| Erasca, Inc. | -3.73 Million USD | -2530.305% |
| bluebird bio, Inc. | -4.03 Million USD | -2335.806% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -347773.698% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 105.155% |
| DBV Technologies S.A. | 15.72 Million USD | 724.129% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -347773.698% |
| Moderna, Inc. | 2.15 Billion USD | 104.555% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -10628.197% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1326.118% |
| Molecular Templates, Inc. | 50.39 Million USD | 294.787% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -18213.993% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 173.372% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1477.676% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -149.506% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 11.667% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -2635.87% |
| MacroGenics, Inc. | 50.52 Million USD | 294.278% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -1509.757% |
| Prime Medicine, Inc. | -147.9 Million USD | 33.631% |
| Aditxt, Inc. | -111.66 Thousand USD | -87812.413% |
| Adagene Inc. | 18.11 Million USD | 641.993% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 20215.369% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 170.015% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 162.193% |
| SciSparc Ltd. | 2.19 Million USD | 4570.082% |
| Vericel Corporation | 135.57 Million USD | 172.404% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -391783.908% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -316738.81% |
| Generation Bio Co. | -73.91 Million USD | -32.812% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -22362.929% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 279.723% |
| Invivyd, Inc. | -2.02 Million USD | -4740.385% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 67.37% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -94800.327% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 201.863% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 199.873% |
| ADMA Biologics, Inc. | 88.21 Million USD | 211.273% |
| Clene Inc. | 533 Thousand USD | 18517.073% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 507.16% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -10157.367% |
| GeoVax Labs, Inc. | -20.72 Million USD | -373.742% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 5037.777% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -50417.199% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 297.095% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -1284.137% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -11641.986% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 217.68% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 134363.869% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 284.649% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 43.32% |
| Trevena, Inc. | 1.45 Million USD | 6846.598% |
| Surrozen, Inc. | -27.23 Million USD | -260.496% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -27708.215% |
| Cingulate Inc. | -582.91 Thousand USD | -16739.933% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -316554.839% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -398.315% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1296637.12% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -11042.225% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 114.421% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -9835.526% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -174127.042% |
| Kronos Bio, Inc. | 1.37 Million USD | 7254.738% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -82.915% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -33517.466% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -20002.434% |
| ImmunityBio, Inc. | -17.89 Million USD | -448.703% |
| Korro Bio, Inc. | -3.63 Million USD | -2604.215% |
| Kineta, Inc. | 5.43 Million USD | 1906.792% |
| BioVie Inc. | -229.37 Thousand USD | -42695.485% |
| Codexis, Inc. | 57.33 Million USD | 271.213% |
| Celularity Inc. | 6.75 Million USD | 1553.19% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 2546.125% |
| Celcuity Inc. | -142.77 Thousand USD | -68655.078% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 194136.371% |
| Cibus, Inc. | 1.42 Million USD | 7003.165% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -26146.791% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -328.304% |
| IN8bio, Inc. | -2.5 Million USD | -3824.95% |
| Kodiak Sciences Inc. | -25.94 Million USD | -278.321% |
| Annexon, Inc. | -3.26 Million USD | -2904.683% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -4702.495% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -135.194% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 15437.969% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 112.609% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 156.756% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -5066.474% |
| Arcellx, Inc. | 108.27 Million USD | 190.657% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -203.262% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 223.937% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -364.084% |
| Moolec Science SA | -143.3 Thousand USD | -68399.355% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -131.965% |
| Geron Corporation | -123.5 Million USD | 20.518% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 3086.401% |
| Royalty Pharma plc | 1.79 Billion USD | 105.472% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -40.053% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -2717591.03% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 42522.998% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 11.893% |
| Humacyte, Inc. | -76.55 Million USD | -28.234% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -10241.939% |
| 89bio, Inc. | -273 Thousand USD | -35857.143% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -7709.308% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -11475.825% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -79707.317% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 8872.386% |
| Notable Labs, Ltd. | 113 Thousand USD | 86969.912% |
| Liquidia Corporation | 14.6 Million USD | 772.349% |
| Mustang Bio, Inc. | -2.22 Million USD | -4311.82% |
| Immunovant, Inc. | -231 Thousand USD | -42394.805% |
| Quantum-Si incorporated | 488 Thousand USD | 20215.369% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -76.682% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -327110.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 5371.912% |
| Acasti Pharma Inc. | -11 Thousand USD | -892290.909% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -47874.02% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -15038.005% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 41.399% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 8751.924% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -25664.567% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -4913.432% |
| PepGen Inc. | -1.18 Million USD | -8190.794% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -77193.701% |
| United Therapeutics Corporation | 2.07 Billion USD | 104.742% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -328.716% |
| Solid Biosciences Inc. | -76.56 Million USD | -28.212% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -118765.868% |
| Immuneering Corporation | -764.13 Thousand USD | -12746.24% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 148239.261% |
| Belite Bio, Inc | -399 Thousand USD | -24502.256% |
| XOMA Corporation | 3.86 Million USD | 2642.424% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -389.933% |
| Bionomics Limited | -434.44 Thousand USD | -22494.827% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -9039.944% |
| uniQure N.V. | 2.21 Million USD | 4531.738% |
| Cassava Sciences, Inc. | -89.42 Million USD | -9.774% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -6.619% |
| Forte Biosciences, Inc. | -9000.00 USD | -1090600.0% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -11656.048% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -22362.929% |
| Altimmune, Inc. | -65.37 Million USD | -50.158% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 127.115% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -9039.944% |
| Compugen Ltd. | 31.45 Million USD | 412.074% |
| Peak Bio, Inc. | 367.76 Thousand USD | 26791.483% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 500.404% |
| Benitec Biopharma Inc. | 108 Thousand USD | 90991.667% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -125750.0% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -8059.85% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -5287.651% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -82389.916% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -8059.85% |
| Instil Bio, Inc. | -4.75 Million USD | -1963.982% |
| argenx SE | 1.1 Billion USD | 108.856% |
| Immunome, Inc. | -8.9 Million USD | -1002.088% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -5093.81% |
| Verona Pharma plc | -679.62 Thousand USD | -14343.722% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -55993.143% |
| Shattuck Labs, Inc. | -2.38 Million USD | -4015.849% |
| CervoMed Inc. | -1.29 Million USD | -7488.2% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -3978.23% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -1954.909% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 4072.602% |
| Moolec Science SA | -143.3 Thousand USD | -68399.355% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -23957.79% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -3574.414% |
| AnaptysBio, Inc. | 14.78 Million USD | 764.116% |
| Design Therapeutics, Inc. | -537 Thousand USD | -18179.888% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -22888.993% |
| NeurAxis, Inc. | 2.15 Million USD | 4651.529% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 4674.231% |
| Lumos Pharma, Inc. | 2 Million USD | 4991.031% |
| Achilles Therapeutics plc | -4.73 Million USD | -1974.772% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -55993.143% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -92791.412% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 410.066% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 11486.432% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -9411.919% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -115.516% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 228386.047% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -11841.971% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -745932.832% |
| Palisade Bio, Inc. | 246 Thousand USD | 40003.659% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -297363.636% |
| Beam Therapeutics Inc. | -59.67 Million USD | -64.504% |
| Neurogene Inc. | -3.26 Million USD | -2909.289% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 170.451% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -2558.803% |
| Sesen Bio, Inc. | 40 Million USD | 345.408% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -32951.515% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -2337.599% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -926.166% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 797.18% |
| Athira Pharma, Inc. | -969 Thousand USD | -10030.341% |
| Vaccinex, Inc. | -16 Million USD | -513.365% |
| HCW Biologics Inc. | -574.82 Thousand USD | -16977.053% |
| XOMA Corporation | 3.86 Million USD | 2642.424% |
| Nektar Therapeutics | 53.47 Million USD | 283.558% |
| Arvinas, Inc. | 71.8 Million USD | 236.717% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -17.615% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -56.373% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -30385.404% |
| Rezolute, Inc. | -36 Thousand USD | -272575.0% |
| Clene Inc. | 533 Thousand USD | 18517.073% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -7644993.458% |
| BeyondSpring Inc. | 1.75 Million USD | 5706.111% |
| Synlogic, Inc. | -1.92 Million USD | -5002.027% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -265205.405% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1450.268% |
| Peak Bio, Inc. | 367.76 Thousand USD | 26791.483% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -417.655% |
| Krystal Biotech, Inc. | 47.6 Million USD | 306.203% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 169.574% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 2053.493% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -3691.22% |
| MannKind Corporation | 136.19 Million USD | 172.077% |
| Ikena Oncology, Inc. | -50.49 Million USD | -94.413% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 190.212% |
| Gossamer Bio, Inc. | -4.38 Million USD | -2138.609% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -38853.571% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1963160.0% |
| Legend Biotech Corporation | 140.92 Million USD | 169.654% |
| Mural Oncology plc | -2.56 Million USD | -3724.036% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -17715.426% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -98063.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 572.984% |
| REGENXBIO Inc. | 53.02 Million USD | 285.112% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1732.441% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -50926.901% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -5567.61% |
| Vaxart, Inc. | -60.76 Million USD | -61.551% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -37255.583% |
| Cellectis S.A. | 18 Thousand USD | 545450.0% |
| Longeveron Inc. | 221 Thousand USD | 44517.647% |
| Repare Therapeutics Inc. | -80.07 Million USD | -22.596% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 108.981% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -7486.012% |
| Revolution Medicines, Inc. | -399.66 Million USD | 75.439% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -280365.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 200432.653% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 101.141% |
| Denali Therapeutics Inc. | -93.34 Million USD | -5.161% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -391783.908% |
| Veru Inc. | 7.56 Million USD | 1397.435% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -64908.609% |
| Cingulate Inc. | -582.91 Thousand USD | -16739.933% |
| Passage Bio, Inc. | -3.72 Million USD | -2538.081% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -814936.533% |
| Exicure, Inc. | -1.42 Million USD | -6798.313% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -25530.026% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 3731.632% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -19047.218% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 244.09% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -65513.908% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -65.799% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 25205.627% |
| OmniAb, Inc. | 14.66 Million USD | 769.278% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 590.987% |
| Lipocine Inc. | -2.85 Million USD | -3343.327% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -5226.262% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1620.649% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -6416.868% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 230.335% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -150920.0% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 216.45% |
| Ocugen, Inc. | -33.53 Million USD | -192.701% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -3004.459% |
| Q32 Bio Inc. | 578 Thousand USD | 17083.218% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -36942.642% |
| Alumis Inc. Common Stock | -1.28 Million USD | -7545.093% |
| Equillium, Inc. | 35.95 Million USD | 372.993% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -5650.615% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 19705.975% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -2374428.302% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -37800.772% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 23322.194% |
| Dominari Holdings Inc. | 2.03 Million USD | 4914.272% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -53403.278% |
| vTv Therapeutics Inc. | -13.59 Million USD | -622.052% |
| Bio-Techne Corporation | 773.07 Million USD | 112.698% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 666.794% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 121.303% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -8297.177% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -309.354% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 939.215% |
| Nkarta, Inc. | -5.86 Million USD | -1572.568% |
| BioCardia, Inc. | -7.24 Million USD | -1254.159% |
| Iterum Therapeutics plc | -1.75 Million USD | -5509.314% |